Terms: = Uterine cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
11 results:
1. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
2. Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via ep300.
Li F; Liang Y; Ying P
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468010
[TBL] [Abstract] [Full Text] [Related]
3. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
Lee TH; Song C; Kim IA; Kim JS; Kim YB; Kim K; No JH; Suh DH; Chung JB; Eom KY
Radiat Oncol; 2021 Aug; 16(1):148. PubMed ID: 34384450
[TBL] [Abstract] [Full Text] [Related]
4. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
5. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
6. Management and outcome of cervical cancer diagnosed in pregnancy.
Bigelow CA; Horowitz NS; Goodman A; Growdon WB; Del Carmen M; Kaimal AJ
Am J Obstet Gynecol; 2017 Mar; 216(3):276.e1-276.e6. PubMed ID: 27810552
[TBL] [Abstract] [Full Text] [Related]
7. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
Chen CC; Lin JC; Jan JS; Ho SC; Wang L
Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
[TBL] [Abstract] [Full Text] [Related]
8. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression.
Fontaine V; van der Meijden E; ter Schegget J
Mol Carcinog; 2001 May; 31(1):27-36. PubMed ID: 11398195
[TBL] [Abstract] [Full Text] [Related]
10. Primary pelvic non-Hodgkin's lymphoma.
Trenhaile TR; Killackey MA
Obstet Gynecol; 2001 May; 97(5 Pt 1):717-20. PubMed ID: 11339922
[TBL] [Abstract] [Full Text] [Related]
11. The endometrium in breast cancer patients on tamoxifen.
Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
[TBL] [Abstract] [Full Text] [Related]
